Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label attachment file name title previous answer version answering member constituency answering member printed answering member label
tabling member	label

Search

1172787

	registered interest
	date	22/01/2020
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty's Government what plans they have, if any, to increase the amount of community care available for dementia patients.
	tabling member printed	Lord Taylor of Warwick
	uin	HL718
	answer	answer is ministerial correction date of answer 29/01/2020 answer text <p>The NHS Long Term Plan, published in January 2019, commits the National Health Service to continuing to improve the care provided to people with dementia and their carers, including through a more active focus on supporting people in the community and ongoing close work with the voluntary sector.</p> answering member printed Baroness Blackwood of North Oxford question first answered 29/01/2020 17:10:43 answering member 4019 label Biography information for Baroness Blackwood of North Oxford
	tabling member	1796 label Biography information for Lord Taylor of Warwick

1175804

	registered interest
	date	22/01/2020
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	house id	2
	legislature	25277 pref label House of Lords
	question text	Her Majesty's Government what rights patients have to see their named GP.
	tabling member printed	Baroness Hodgson of Abinger
	uin	HL687
	answer	answer is ministerial correction date of answer 05/02/2020 answer text <p>The legal responsibilities of the named accountable general practitioner (GP) are set out in the National Health Service (General Medical Services [GMS] Contracts) Regulations 2004 (as amended). The contract (and amendments) include a requirement for all patients to be assigned a named accountable GP who has overall responsibility for that patient’s care. This does not necessarily mean that patients will see their named accountable GP for every appointment. Patients can still request to see a particular GP, although they may have to wait longer for an appointment if they do so.</p><p>The Department has not made a formal assessment into the impact and role of named accountable GPs.</p><p>Under the terms of the GMS Regulations, the named accountable GP must take lead responsibility for the coordination of all services required under the contract and ensure they are delivered to each of their patients where required (based on the clinical judgment of the named accountable GP). The 2015/16 GMS Contract Guidance (published in March 2015) provides further information on named accountable GPs for all patients. A copy is attached. The guidance states: ‘Where the patient expresses a preference as to which GP they have been assigned, the practice must make reasonable efforts to accommodate this request’. This document provides guidance for commissioners, local medical committees and GP practices. This information is also of use to individuals because it explains how named accountable GPs should interact with their patients. The British Medical Association (BMA) has also provided guidance on how practices can fulfil the requirement to provide named accountable GPs for their patients.</p><p>Every patient can request to see a specific GP, including their named accountable GP. Under the terms of their contract (as set out in Schedule 3, Part 2 of the Regulations), the GP practice must endeavour to comply with all reasonable requests of patients to see a particular practitioner. Authorised family members have the same rights.</p><p>Data is not held centrally on the percentage of named accountable GPs in England who have seen the patients they are accountable for.</p><p> </p> answering member printed Baroness Blackwood of North Oxford grouped question UIN HL684 HL685 HL686 HL688 HL689 question first answered 05/02/2020 15:43:04 answering member 4019 label Biography information for Baroness Blackwood of North Oxford attachment 1 file name GMS-Guidance.pdf title General Medical Services (GMS) contract
	tabling member	4301 label Biography information for Baroness Hodgson of Abinger

1172655

	registered interest
	date	22/01/2020
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Accident and Emergency Departments: Lincolnshire
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, how many patients attended A&E at (a) Grantham and District Hospital, (b) Pilgrim Hospital Boston and (c) Lincoln County Hospital in (i) 2016, (ii) 2017, (iii) 2018 and (iv) 2019.
	tabling member constituency	Grantham and Stamford
	tabling member printed	Gareth Davies
	uin	6755
	answer	answer is ministerial correction date of answer 30/01/2020 answer text <p>The information is not available in the format requested. The available information in the following table shows the number of unplanned accident and emergency (A&amp;E) attendance, at Grantham and District Hospital, Pilgrim Hospital Boston and Lincoln County Hospital in 2016/17, 2017/18 and 2018/19.</p><p><br> It should be noted that the number of admissions will include those patients that attended A&amp;E more than once.</p><p> </p><table><tbody><tr><td><p>National Health Service Provider</p></td><td><p>2016-17</p></td><td><p>2017-18</p></td><td><p>2018-19</p></td></tr><tr><td><p>Lincoln County Hospital</p></td><td><p>71,455</p></td><td><p>67,825</p></td><td><p>70,650</p></td></tr><tr><td><p>Pilgrim Hospital Boston</p></td><td><p>57,360</p></td><td><p>57,235</p></td><td><p>52,635</p></td></tr><tr><td><p>Grantham and District Hospital</p></td><td><p>24,115</p></td><td><p>22,750</p></td><td><p>23,755</p></td></tr></tbody></table><p>Source: Hospital Episode Statistics, NHS Digital</p><p> </p> answering member constituency Charnwood answering member printed Edward Argar question first answered 30/01/2020 15:38:53 answering member 4362 label Biography information for Edward Argar
	tabling member	4850 label Biography information for Gareth Davies

1172698

	registered interest
	date	22/01/2020
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Blood Cancer
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what plans he has to reduce the number of people with blood cancer visiting their GP three or more times.
	tabling member constituency	Crawley
	tabling member printed	Henry Smith
	uin	6642
	answer	answer is ministerial correction date of answer 31/01/2020 answer text <p>In 2020, NHS England and NHS Improvement will continue to roll-out Rapid Diagnostic Centres across the country to upgrade and bring together the latest diagnostic equipment and expertise. They will initially focus on diagnosing cancers where patients often present with non-specific symptoms, such as blood cancer, and may go to their general practitioner many times before being sent for appropriate tests.</p><p> </p><p> </p><p> </p> answering member constituency Bury St Edmunds answering member printed Jo Churchill question first answered 31/01/2020 11:10:11 answering member 4380 label Biography information for Jo Churchill
	tabling member	3960 label Biography information for Henry Smith

1172720

	registered interest
	date	22/01/2020
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Cannabis: Medical Treatments
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what the average cost to the NHS was of prescriptions for unlicensed cannabis-based products for medicinal use from November 2018 to October 2019.
	tabling member constituency	Wyre Forest
	tabling member printed	Mark Garnier
	uin	6669
	answer	answer is ministerial correction date of answer 30/01/2020 answer text <p>The average cost to the National Health Service of all prescriptions for unlicensed cannabis-based products dispensed in the community from November 2018 to October 2019 was £2,789.21 per prescription.</p><p>The NHS Business Services Authority does not hold data for prescriptions dispensed by hospital pharmacies, including for Nabilone, Sativex, Epidyolex* and unlicensed cannabis-based products for medicinal use. This information is not held centrally and is not routinely published. Intelligence from NHS England and NHS Improvement Controlled Drugs Accountable Officers is that a low number of patients are receiving prescriptions for cannabis-based products for medicinal use in independent secondary/tertiary care in England. However, this data is not collected nationally or routinely published.</p><p>In October 2019, for prescriptions issued by private healthcare specialist prescribers and dispensed in the community, there were no prescriptions for Nabilone, one prescription for Sativex, and 33 prescriptions for unlicensed cannabis-based products.</p><p>Finally, there was one prescription for unlicensed cannabis-based products prescribed on the NHS and dispensed in the community in October 2019.</p><p>Note:</p><p>*Epidyolex was unlicensed prior to September 2019; no NHS prescriptions for Epidyolex have been recorded as submitted to the NHS Business Services Authority at the time of this request. Approximately 185 patients have accessed Epidyolex through the manufacturer’s (GW Pharma) early access programmes, ahead of a licensing decision by the European Medicines Agency.</p><p> </p><p> </p><p><strong> </strong></p><p><strong> </strong></p> answering member constituency Bury St Edmunds answering member printed Jo Churchill grouped question UIN 6670 6671 6672 question first answered 30/01/2020 15:34:44 answering member 4380 label Biography information for Jo Churchill
	tabling member	4074 label Biography information for Mark Garnier

1172721

	registered interest
	date	22/01/2020
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Cannabis: Medical Treatments
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, how many prescriptions for (a) Nabilone Savitex, (b) Epidiolex and (c) unlicensed cannabis-based products for medicinal use were dispensed by hospital pharmacies from November 2018 to October 2019.
	tabling member constituency	Wyre Forest
	tabling member printed	Mark Garnier
	uin	6670
	answer	answer is ministerial correction date of answer 30/01/2020 answer text <p>The average cost to the National Health Service of all prescriptions for unlicensed cannabis-based products dispensed in the community from November 2018 to October 2019 was £2,789.21 per prescription.</p><p>The NHS Business Services Authority does not hold data for prescriptions dispensed by hospital pharmacies, including for Nabilone, Sativex, Epidyolex* and unlicensed cannabis-based products for medicinal use. This information is not held centrally and is not routinely published. Intelligence from NHS England and NHS Improvement Controlled Drugs Accountable Officers is that a low number of patients are receiving prescriptions for cannabis-based products for medicinal use in independent secondary/tertiary care in England. However, this data is not collected nationally or routinely published.</p><p>In October 2019, for prescriptions issued by private healthcare specialist prescribers and dispensed in the community, there were no prescriptions for Nabilone, one prescription for Sativex, and 33 prescriptions for unlicensed cannabis-based products.</p><p>Finally, there was one prescription for unlicensed cannabis-based products prescribed on the NHS and dispensed in the community in October 2019.</p><p>Note:</p><p>*Epidyolex was unlicensed prior to September 2019; no NHS prescriptions for Epidyolex have been recorded as submitted to the NHS Business Services Authority at the time of this request. Approximately 185 patients have accessed Epidyolex through the manufacturer’s (GW Pharma) early access programmes, ahead of a licensing decision by the European Medicines Agency.</p><p> </p><p> </p><p><strong> </strong></p><p><strong> </strong></p> answering member constituency Bury St Edmunds answering member printed Jo Churchill grouped question UIN 6669 6671 6672 question first answered 30/01/2020 15:34:44 answering member 4380 label Biography information for Jo Churchill
	tabling member	4074 label Biography information for Mark Garnier

1172722

	registered interest
	date	22/01/2020
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Cannabis: Medical Treatments
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, how many prescriptions for (a) Nabilone, (b) Savitex and (c) unlicensed cannabis-based products for medicinal use were issued by private healthcare specialist prescribers and dispensed in the community in October 2019.
	tabling member constituency	Wyre Forest
	tabling member printed	Mark Garnier
	uin	6671
	answer	answer is ministerial correction date of answer 30/01/2020 answer text <p>The average cost to the National Health Service of all prescriptions for unlicensed cannabis-based products dispensed in the community from November 2018 to October 2019 was £2,789.21 per prescription.</p><p>The NHS Business Services Authority does not hold data for prescriptions dispensed by hospital pharmacies, including for Nabilone, Sativex, Epidyolex* and unlicensed cannabis-based products for medicinal use. This information is not held centrally and is not routinely published. Intelligence from NHS England and NHS Improvement Controlled Drugs Accountable Officers is that a low number of patients are receiving prescriptions for cannabis-based products for medicinal use in independent secondary/tertiary care in England. However, this data is not collected nationally or routinely published.</p><p>In October 2019, for prescriptions issued by private healthcare specialist prescribers and dispensed in the community, there were no prescriptions for Nabilone, one prescription for Sativex, and 33 prescriptions for unlicensed cannabis-based products.</p><p>Finally, there was one prescription for unlicensed cannabis-based products prescribed on the NHS and dispensed in the community in October 2019.</p><p>Note:</p><p>*Epidyolex was unlicensed prior to September 2019; no NHS prescriptions for Epidyolex have been recorded as submitted to the NHS Business Services Authority at the time of this request. Approximately 185 patients have accessed Epidyolex through the manufacturer’s (GW Pharma) early access programmes, ahead of a licensing decision by the European Medicines Agency.</p><p> </p><p> </p><p><strong> </strong></p><p><strong> </strong></p> answering member constituency Bury St Edmunds answering member printed Jo Churchill grouped question UIN 6669 6670 6672 question first answered 30/01/2020 15:34:45 answering member 4380 label Biography information for Jo Churchill
	tabling member	4074 label Biography information for Mark Garnier

1172724

	registered interest
	date	22/01/2020
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Cannabis: Medical Treatments
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, how many prescriptions for unlicensed cannabis-based products for medicinal use were prescribed by the NHS and dispensed in the community in October 2019.
	tabling member constituency	Wyre Forest
	tabling member printed	Mark Garnier
	uin	6672
	answer	answer is ministerial correction date of answer 30/01/2020 answer text <p>The average cost to the National Health Service of all prescriptions for unlicensed cannabis-based products dispensed in the community from November 2018 to October 2019 was £2,789.21 per prescription.</p><p>The NHS Business Services Authority does not hold data for prescriptions dispensed by hospital pharmacies, including for Nabilone, Sativex, Epidyolex* and unlicensed cannabis-based products for medicinal use. This information is not held centrally and is not routinely published. Intelligence from NHS England and NHS Improvement Controlled Drugs Accountable Officers is that a low number of patients are receiving prescriptions for cannabis-based products for medicinal use in independent secondary/tertiary care in England. However, this data is not collected nationally or routinely published.</p><p>In October 2019, for prescriptions issued by private healthcare specialist prescribers and dispensed in the community, there were no prescriptions for Nabilone, one prescription for Sativex, and 33 prescriptions for unlicensed cannabis-based products.</p><p>Finally, there was one prescription for unlicensed cannabis-based products prescribed on the NHS and dispensed in the community in October 2019.</p><p>Note:</p><p>*Epidyolex was unlicensed prior to September 2019; no NHS prescriptions for Epidyolex have been recorded as submitted to the NHS Business Services Authority at the time of this request. Approximately 185 patients have accessed Epidyolex through the manufacturer’s (GW Pharma) early access programmes, ahead of a licensing decision by the European Medicines Agency.</p><p> </p><p> </p><p><strong> </strong></p><p><strong> </strong></p> answering member constituency Bury St Edmunds answering member printed Jo Churchill grouped question UIN 6669 6670 6671 question first answered 30/01/2020 15:34:45 answering member 4380 label Biography information for Jo Churchill
	tabling member	4074 label Biography information for Mark Garnier

1172522

	registered interest
	date	22/01/2020
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Care Homes
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what recent assessment his Department has made of trends in the number of people moved from home care into residential care since 2015.
	tabling member constituency	Cardiff Central
	tabling member printed	Jo Stevens
	uin	6715
	answer	answer is ministerial correction date of answer 28/01/2020 answer text <p>The Department does not hold data on the number of clients moving between long term care settings therefore no assessment has been made.</p><p> </p><p> </p> answering member constituency Gosport answering member printed Caroline Dinenage question first answered 28/01/2020 17:26:40 answering member 4008 label Biography information for Dame Caroline Dinenage previous answer version 3025 answering member constituency Gosport answering member printed Caroline Dinenage answering member 4008 label Biography information for Dame Caroline Dinenage
	tabling member	4425 label Biography information for Jo Stevens

1172635

	registered interest
	date	22/01/2020
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Children: Death
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, which NHS hospital trusts do not currently have a designated doctor for child deaths in post.
	tabling member constituency	East Worthing and Shoreham
	tabling member printed	Tim Loughton
	uin	6594
	answer	answer is ministerial correction date of answer 29/01/2020 answer text <p>The Department does not hold the information requested.</p> answering member constituency Mid Bedfordshire answering member printed Ms Nadine Dorries question first answered 29/01/2020 13:47:28 answering member 1481 label Biography information for Ms Nadine Dorries previous answer version 3031 answering member constituency Mid Bedfordshire answering member printed Ms Nadine Dorries answering member 1481 label Biography information for Ms Nadine Dorries
	tabling member	114 label Biography information for Tim Loughton